HOLISTA COLLTECH LIMITED — Capital/Financing Update 2018

Aug 5, 2018

==> picture [215 x 49] intentionally omitted <==

Holista CollTech Limited (ASX:HCT / ABN 24 094 515 992) 283 Rokeby Road Subiaco WA 6008 P: +61 8 6141 3500 ; F: +61 8 6141 3599 W: www.holistaco.com

ASX Announcement

6 August 2018

HOLISTA COLLTECH LIMITED SHARE PURCHASE PLAN

SHARE PURCHASE PLAN

Holista CollTech Limited ( Holista , or the Company ) (ASX CODE: HCT) is pleased to advise that the Share Purchase Plan ( SPP ) which was announced on 26 June 2018 has closed. Under the SPP, each Eligible Shareholder was entitled to subscribe for up to $15,000 of new fully paid ordinary shares (Shares) at an issue price of 7 cents per Share.

The Company received applications for a total of 8,576,525 new Shares from Eligible Shareholders and has elected to accept all shareholder subscriptions.

Dr Rajen Manicka, Managing Director said “the strong support the Company has received from its existing shareholders is encouraging and places Holista in a strong position to accelerate the growth plan.”

SPP UNDERWRITING SHARE ISSUES

The Company further advises that an additional 31,423,475 new Shares will be taken up by the underwriters Dr Rajen Manicka and Mr Chan Heng Fai and their nominees. The issue of SPP Underwriting Shares was approved by shareholders at a General Meeting held on 30 July 2018. Dr Rajen Manicka and Mr Chan Heng Fai set off amounts payable to them by the Company of $362,661, and $75,710, respectively, against their Underwriting commitments.

The new shares are issued on the same terms as, and will rank equally in all respects with, the existing fully paid ordinary shares in the Company.

The funds raised are to be used to fund marketing of the Company’s low GI noodle product in China and USA, and for product development.

The Company anticipates that the issue of the SPP Shares to Eligible Shareholders, and the SPP Underwriting Shares to the Underwriters and their nominees, will take place on 6 August 2018, with dispatch of holding statements expected to occur on or around 7 August 2018.

ENDS

==> picture [145 x 33] intentionally omitted <==

For further information, please contact:

Corporate Affairs & Business Opportunities

Dr Rajen Manicka: rajen.m@holistaco.com General Enquiries: enquiries@holistaco.com

Australia

283 Rokeby Road Subiaco WA 6008 P: +61 8 6141 3500 ; F: +61 8 6141 3599

Malaysia

12th Floor, Amcorp Trade Centre, PJ Tower No. 18, Persiaran Barat off Jalan Timur 46000, Petaling Jaya, Malaysia P: +603 7965 2828 ; F: +603 7965 2777

Media and Investor Relations Enquiries

WeR1 Consultants Pte Ltd 3 Phillip Street #12-01 Singapore 048693 Roshan Singh, roshansingh@wer1.net; P: +65 67374844

About Holista CollTech Ltd

Holista CollTech Ltd ( Holista ) is a research-driven biotech company and is the result of the merger of Holista Biotech Sdn Bhd and CollTech Australia Ltd. Headquartered in Perth with extensive operations in Malaysia, Holista is dedicated to delivering first-class natural ingredients and wellness products and leads in research on herbs and food ingredients.

Holista, listed on the Australia Securities Exchange, researches, develops, manufactures and markets “healthstyle” products to address the unmet and growing needs of natural medicine. Holista’s suite of ingredients is capable of serving the industry to provide low-GI baked products, low sodium salt, low fat fried foods and low calories sugar without compromise in taste, odour and mouth feel. It is the only company to produce sheep (ovine) collagen using patented extraction methods.